Hematology Analyzer DxH 900 CLIA Non-Waived

Features

• The DxH 900 Hematology Analyzer delivers accurate, first-analysis results through proprietary VCS technology
• The analyzer is compatible with clinical informatics and automation solutions to form scalable, customized solutions
• Deliver reliable, reportable WBC differential results on the first run, through VCS technology, DataFusion and the enhanced Coulter Principle
• The enhanced Coulter Principle provides a reportable MPV - even for thrombocytopenic patients - while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences
• Assess anemia with accuracy by maintaining near native-state cellular characterization throughout the RBC maturation cycle
• Utilize a new reportable parameter for the emergency department to identify the possibility of infection earlier to stop potentially deadly complications from developing or progressing, helping to reduce the cost of care
• Streamline QA/QC processes through customizable, automated technology with daily reminders and remote support
• Maximize efficiency with one-touch sample processing with total laboratory automation and clinical information management tools
• Optimize operations through a seamless workflow, small footprint, intuitive software and easy maintenance
• Exclusive to the DxH 900 and 690T analyzers is the regulatory-cleared hematological biomarker Monocyte Distribution Width (MDW) that aids physicians in identifying severity of infection and risk of sepsis in adult Emergency Department patients; this marker is available early in patient assessment as part of a CBC-Diff test with no impact to workflow